van Tol EA - Search Results

1

Modulatory effects of VIP and related peptides from the gastrointestinal tract on cell mediated cytotoxicity against tumour cells in vitro.

van Tol EA, Verspaget HW, Peña AS, Jansen JB, Aparicio-Pagés MN, Lamers CB. van Tol EA, et al. Immunol Invest. 1991 Jun;20(3):257-67. doi: 10.3109/08820139109026229. Immunol Invest. 1991. PMID: 1874558

2

The CD56 adhesion molecule is the major determinant for detecting non-major histocompatibility complex-restricted cytotoxic mononuclear cells from the intestinal lamina propria.

Van Tol EA, Verspaget HW, Peña AS, Kraemer CV, Lamers CB. Van Tol EA, et al. Eur J Immunol. 1992 Jan;22(1):23-9. doi: 10.1002/eji.1830220105. Eur J Immunol. 1992. PMID: 1370415

3

Normal inflammatory bowel disease mucosa conceals alterations in natural killer cell activity.

van Tol EA, Verspaget HW, Peña AS, Lamers CB. van Tol EA, et al. Scand J Gastroenterol. 1992 Dec;27(12):999-1005. doi: 10.3109/00365529209028129. Scand J Gastroenterol. 1992. PMID: 1475629

4

Neuropeptide regulation of cell-mediated cytotoxicity against human tumor cells.

Van Tol EA, Verspaget HW, Lamers CB. Van Tol EA, et al. Neuropeptides. 1990 May;16(1):25-32. doi: 10.1016/0143-4179(90)90026-u. Neuropeptides. 1990. PMID: 1701225

5

Intravenous administration of bombesin in man stimulates natural killer cell activity against tumour cells.

van Tol EA, Elzo Kraemer CV, Verspaget HW, Masclee AA, Lamers CB. van Tol EA, et al. Neuropeptides. 1991 Jan;18(1):15-21. doi: 10.1016/0143-4179(91)90158-f. Neuropeptides. 1991. PMID: 2046885

6

In vitro cellular cytotoxicity in Crohn's disease and ulcerative colitis: relation with disease activity and treatment, and the effect of recombinant gamma-interferon.

Aparició-Pagés MN, Verspaget HW, Peña AS, Weterman IT, de Bruin PA, Mieremet-Ooms MA, van der Zon JM, van Tol EA, Lamers CB. Aparició-Pagés MN, et al. Among authors: van der zon jm, van tol ea. J Clin Lab Immunol. 1989 Jul;29(3):119-24. J Clin Lab Immunol. 1989. PMID: 2517428

7

Effects of CCK-8 and CCK-33 on human natural killer cell activity: studies on intestinal lamina propria and peripheral blood mononuclear cells.

van Tol EA, Verspaget HW, Lamers CB. van Tol EA, et al. Immunopharmacology. 1993 Jan-Feb;25(1):11-8. doi: 10.1016/0162-3109(93)90026-m. Immunopharmacology. 1993. PMID: 8320079

8

Neuroenteric peptides affect natural killer activity by intestinal lamina propria mononuclear cells.

van Tol EA, Verspaget HW, Hansen BE, Lamers CB. van Tol EA, et al. J Neuroimmunol. 1993 Feb;42(2):139-45. doi: 10.1016/0165-5728(93)90003-h. J Neuroimmunol. 1993. PMID: 8429099

9

Effect of zinc therapy on natural killer cell activity in inflammatory bowel disease.

Van de Wal Y, Van der Sluys Veer A, Verspaget HW, Mulder TP, Griffioen G, Van Tol EA, Peña AS, Lamers CB. Van de Wal Y, et al. Among authors: van tol ea, van der sluys veer a. Aliment Pharmacol Ther. 1993 Jun;7(3):281-6. doi: 10.1111/j.1365-2036.1993.tb00099.x. Aliment Pharmacol Ther. 1993. PMID: 8364133 Clinical Trial.

10

Detection of cells with NK activity from histologically normal mucosa in relation to disease.

van Tol EA, Verspaget HW, Peña AS, Lamers CB. van Tol EA, et al. Adv Exp Med Biol. 1995;371A:313-6. doi: 10.1007/978-1-4615-1941-6_65. Adv Exp Med Biol. 1995. PMID: 8525933 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters